From Wikipedia, the free encyclopedia
JWH-200 is an analgesic chemical from the aminoalkylindole family, which acts as a cannabinoid receptor agonist. Its binding affinity at the CB1 receptor is 42nM, around the same as that of THC,[1] but interestingly, its analgesic potency in vivo was higher than that of other analogues with stronger CB1 binding affinity in vitro,[2] around 3 times that of THC but with less sedative effect,[3] most likely reflecting favourable pharmacokinetic characteristics.
References
- ^ Huffman JW, Padgett LW. Recent Developments in the Medicinal Chemistry of Cannabimimetic Indoles, Pyrroles and Indenes. Current Medicinal Chemistry, 2005; 12: 1395-1411.
- ^ Bell MR, D'Ambra TE, Kumar V, et al. (1991). Antinociceptive (aminoalkyl)indoles. Journal of Medicinal Chemistry. 34 (3): 1099–1110. PMID 1900533
- ^ Compton DR, Gold LH, Ward SJ, Balster RL, Martin BR (1992). Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol. Journal of Pharmacology and Experimental Therapeutics. 263 (3): 1118–26. PMID 1335057
| Cannabinoids |
|---|
|
| Plant cannabinoids | | |
| Cannabinoid metabolites | | |
| Endogenous cannabinoids | | |
Synthetic cannabinoid receptor agonists | Classical cannabinoids (Dibenzopyrans) | | |
Nonclassical cannabinoids | | |
Aminoalkylindoles | | |
Aminoalkylpyrroles | | |
Eicosanoids | AM-883 • Arachidonyl-2'-chloroethylamide • Arachidonylcyclopropylamide • Methanandamide • O-585 • O-689 • O-1812 •O-1860 • O-1861 | |
Others | |
| |
Endocannabinoid activity enhancers | | |
Cannabinoid receptor antagonists and inverse agonists | |
|